High incidence of hepatitis C virus reinfection in a cohort of injecting drug users

Abstract

Our data suggest that HCV infection in IDUs is more likely following prior infection and clearance than in HCV-naive individuals, implying no increased immunity against further infection. This result has important implications for the future development of an HCV vaccine.